Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

PSMA-targeting fluorescent imaging agent IS-002

A near-infrared (NIR) fluorescent imaging agent targeting the tumor-associated antigen (TAA) prostate-specific membrane antigen (PSMA), that can potentially be used as a tumor-selective fluorescent imaging agent during NIR fluorescence imaging-guided surgery. Upon intravenous administration, the PSMA-targeting fluorescent imaging agent IS-002 targets and binds to PSMA on PSMA-expressing tumor cells. Upon fluorescent imaging, PSMA-expressing tumors can be visualized and identified, and surgically removed. PSMA is overexpressed by most prostate cancers.
Synonym:fluorophore IS-002
PSMA-targeted fluorescent imaging agent IS-002
Code name:IS 002
IS-002
IS002
Search NCI's Drug Dictionary